Cargando...
Novel therapies in thrombotic thrombocytopenic purpura
ESSENTIALS: The standard of care for patients with TTP remains daily plasma exchange in addition to immune suppressive therapy. Despite the improved treatment options for TTP, the acute mortality of TTP remains between 15‐20%. Caplacizumab reduces the time to platelet recovery and the exacerbation r...
Guardado en:
| Publicado en: | Res Pract Thromb Haemost |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6055500/ https://ncbi.nlm.nih.gov/pubmed/30046703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12066 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|